125742 45 S211 M5 c4591001 A 6mth report cci pulmonary 30oct2020
Document text
CCI_Pulmonary MedDRA Dictionary Version: 230 Status: ACTIVETerm Name: CCI_PulmonaryCode: 90002942Extension: CCIReport Date/Time: 27-Oct-2020:10:53:42 AM EDT Term Code Level Categor yWeight Scope Pulmonary pneumatocele 10063749 PT Pulmonary ossification 10070310 PT Pulmonary necrosis 10058824 PT Pulmonary interstitial emphysema syndrome 10037415 PT Pulmonary hypertensive crisis 10068726 PT Pulmonary hypertension 10037400 PT Pulmonary fibrosis 10037383 PT Pulmonary eosinophilia 10037382 PT Pulmonary cavitation 10051738 PT Pulmonary calcification 10051200 PT Pulmonary artery wall hypertrophy 10063561 PT Pulmonary arterial hypertension 10064911 PT Pulmonary amyloidosis 10063945 PT Pulmonary alveolar microlithiasis 10037315 PT Progressive massive fibrosis 10036805 PT Portopulmonary hypertension 10067281 PT Pneumonitis 10035742 PT Pneumoconiosis 10035653 PT Organic dust toxic syndrome 10075078 PT Occupational asthma 10070836 PT Obstructive airways disorder 10061877 PT Obliterative bronchiolitis 10029888 PT Noninfective bronchitis 10062644 PT Middle lobe syndrome 10056652 PT MacLeod's syndrome 10025375 PT Loeffler's syndrome 10024794 PT Interstitial lung disease 10022611 PT Infective exacerbation of chronic obstructive airways disease 10056971 PTInfective exacerbation of bronchiectasis 10070295 PT Childhood asthma 10081274 PT Idiopathic pulmonary fibrosis 10021240 PT Idiopathic pneumonia syndrome 10063725 PT Idiopathic interstitial pneumonia 10078268 PT Granulomatous pneumonitis 10069152 PT Fibrinous bronchitis 10051011 PT 090177e198d55510\Final\Final On: 10-Dec-2021 03:00 (GMT) FDA-CBER-2022-5812-0219810 Eosinophilic bronchitis 10065563 PT Emphysema 10014561 PT Dust inhalation pneumopathy 10061112 PT Diffuse panbronchiolitis 10062952 PT Diffuse alveolar damage 10060902 PT Cor pulmonale chronic 10010970 PT Cor pulmonale 10010968 PT Combined pulmonary fibrosis and emphysema 10076515 PT Chronic respiratory failure 10009126 PT Chronic respiratory disease 10061768 PT Chronic obstructive pulmonary disease 10009033 PT Byssinosis 10006822 PT Cystic lung disease 10078811 PT Bronchostenosis 10006487 PT Bronchospasm paradoxical 10006486 PT Bronchospasm 10006482 PT Bronchopulmonary disease 10053420 PT Bronchopulmonary aspergillosis 10006473 PT Bronchitis chronic 10006458 PT Bronchiectasis 10006445 PT Bronchial obstruction 10006440 PT Berylliosis 10004485 PT Atelectasis 10003598 PT Asthmatic crisis 10064823 PT Asthma-chronic obstructive pulmonary disease overlap syndrome 10077005 PT Asthma late onset 10003559 PT Asthma exercise induced 10003557 PT Asthma 10003553 PT Aspirin-exacerbated respiratory disease 10075084 PT Asbestosis 10003441 PT Alveolitis necrotising 10050343 PT Hypersensitivity pneumonitis 10081988 PT Alveolitis 10001889 PT Alveolar proteinosis 10001881 PT Alveolar lung disease 10073344 PT Allergic bronchitis 10052613 PT Airway remodelling 10075289 PT Acute interstitial pneumonitis 10066728 PT Systemic sclerosis pulmonary 10042954 PT Status asthmaticus 10041961 PT Silicosis 10040678 PT Reversible airways obstruction 10062109 PT Restrictive pulmonary disease 10048667 PT Respiratory fume inhalation disorder 10061485 PT Reactive airways dysfunction syndrome 10070832 PT Radiation fibrosis - lung 10037758 PT Pulmonary sarcoidosis 10037430 PT Pulmonary radiation injury 10061473 PT 090177e198d55510\Final\Final On: 10-Dec-2021 03:00 (GMT) FDA-CBER-2022-5812-0219811